Dr. Joe Galati\'s Blog
Discussions about the liver and everything else related to health and wellness.
This week, we will be starting therapy using the new FDA approved protease inhibitors, Victrelis (boceprevir) and Incivek (telaprevir) in our patients with chronic hepatitis C.
Below is a brief podcast explaining some of the procedures required prior to initiating therapy with these new agents.
Listen to the podcast here: Hepatitis C Treatment Introduction
Call our office at 713-794-0700 if you have questions.
Liver Specialists of Texas
6624 Fannin, Suite 1990
Houston, TX 77030
Telaprevir and FDA Approval: The Race is On for New Hepatitis C Drugs
The MELD Score and Liver Transplant: An Update for Patients
MELD Score and the Question of When I am Getting My Liver?
Dr. Joseph S. Galati is a native of Long Island, New York. He received his undergraduate degree at Syracuse University and attended St. George's University School of Medicine.
Following medical school, Dr. Galati was an Intern and Resident in Internal Medicine at State University of New York Health Science Center-Brooklyn (formerly Downstate Medical Center)/Kings County Hospital Center, one of the premier teaching hospitals in the country. He remained an additional year in the department to assume responsibilities as the Chief Medical Resident in the Department of Medicine under the direction of Dr. Donald E. Wilson, currently the Dean at the University of Maryland School of Medicine. Read more...
Dr. Galati you have all my labs Iwas wondering i would be a candidate for treatment Thanks Gary Allen
Call Herman and have him review them.